Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer

Kohei Shigeta, Hirotoshi Hasegawa, Koji Okabayashi, Masashi Tsuruta, Yoshiyuki Ishii, Takashi Endo, Hiroki Ochiai, Takayuki Kondo, Yuko Kitagawa

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences